Google is attempting to make it easier for developers to access its documentation by creating the Developer Knowledge API and corresponding MCP server, both now in public preview.

Agentic Postgres from Tiger Data offers persistent memory and BM25 search, helping you build faster and add Stripe payments ...

OpenAI Chief Executive Officer Sam Altman said his company may consider investing in or subsidizing firms that make significant use of its AI technologies to discover new drugs or therapies, and ...

Part 4 of the TED Radio Hour episode What can you control in this chaotic world? What do you want out of life? Instead of ignoring daunting questions like this, designer Bill Burnett says we should ...

Some of the country’s most pressing problems have a simple solution — remove the regulatory obstacles that slow progress. One obvious example is housing. The best way to reduce the cost of housing isn ...

Forbes contributors publish independent expert analyses and insights. Anisha Sircar is a journalist covering tech, finance and society. This voice experience is generated by AI. Learn more. This voice ...

For the fastest way to join Tom's Guide Club enter your email below. We'll send you a confirmation and sign you up to our newsletter to keep you updated on all the latest news. By submitting your ...

When scientists repeatedly drove a strongly interacting quantum system with laser “kicks,” they expected it to heat up and grow chaotic. Instead, the atoms abruptly stopped absorbing energy and locked ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The new facility will be for a ...

Jan 6 (Reuters) - Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence on genetic data to discover new drug candidates to send into human ...

Matthew Lees is supported by a Canadian Institutes of Health Research (CIHR) Postdoctoral Fellowship award (Funding Reference Number 187773). Tom Janssen does not work for, consult, own shares in or ...

Alex Zhavoronkov, Founder and CEO of generative-AI drug discovery firm Insilico Medicine, discusses the company's plans after it raised $293 million in its initial public offering in Hong Kong. He ...